Posted 05.15.2019 | by AMRA
There are certain similarities between the increased awareness associated with the practice of mindfulness and the expanded consciousness associated with the use of psychedelic substances. Both are capable of promoting states of self-transcendence in which the boundary between one’s self and the world is erased, leading to a boundless sense of connection with the universe.
Smigielski et al. [Neuroimage] experimentally tested the effects of psilocybin, a psychedelic mushroom plant derivative, on self-reported, neurological, and behavioral outcomes among experienced meditators attending a meditation retreat.
The researchers randomly assigned 38 experienced meditators (average meditation experience = 5,000 hours; 61% male; average age = 52 years) on a five-day Zen meditation retreat to a psilocybin or placebo control condition. On the morning of the fourth retreat day, participants were administered either psilocybin (315 μgs/kg) or a placebo (lactose), and continued on with the regular retreat schedule. The research participants and assessors were blinded to the study group assignment.
Six hours after psilocybin or placebo administration, participants completed a questionnaire measuring psychological factors such as “oceanic self-boundlessness,” “dread of ego dissolution,” visual and auditory hallucinations, synesthesia, and “vigilance reduction.”
On the day before and after the retreat, participants underwent brain imaging (fMRI) to measure functional connectivity in the Default Mode Network (DMN) while resting, while engaging in focused attention meditation, and while engaging in open awareness meditation. The DMN is a network of brain regions that operates collectively when a person is simply resting and “doing nothing.”
DMN activity has been implicated in self-referential thinking, maintaining a unitary sense of identity, and maintaining the self-other boundary. Functional connectivity is a measure of the degree to which different brain regions are operationally […]